A

Apogenix Ltd

28 employees

Apogenix is a biopharmaceutical company developing novel protein therapeutics for the treatment of cancer and inflammatory diseases.

Basic info

Industry

biotechnology research

Sectors

COVID-19
TNF superfamily signaling
Biotechnology
CD95
Health Care
Therapeutics
Glioblastoma
Drug candidates for cancer treatment
Development of immunotherapeutics
Myelodysplastic syndromes

Date founded

2005

Funding rounds raised

Total raised

$3.3M

from 1 investors over 1 rounds

A

Apogenix Ltd raised $3.3M on February 16, 2016

Investors: Federal Ministry of Education and Research, Germany

FAQ